title: Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation.
abstract: While several clinical studies have shown that HIV-1 infection is associated with increased permeability of the intestinal tract, there is very little understanding of the mechanisms underlying HIV-induced impairment of mucosal barriers. Here we demonstrate that exposure to HIV-1 can directly breach the integrity of mucosal epithelial barrier, allowing translocation of virus and bacteria. Purified primary epithelial cells (EC) isolated from female genital tract and T84 intestinal cell line were grown to form polarized, confluent monolayers and exposed to HIV-1. HIV-1 X4 and R5 tropic laboratory strains and clinical isolates were seen to reduce transepithelial resistance (TER), a measure of monolayer integrity, by 30-60% following exposure for 24 hours, without affecting viability of cells. The decrease in TER correlated with disruption of tight junction proteins (claudin 1, 2, 4, occludin and ZO-1) and increased permeability. Treatment of ECs with HIV envelope protein gp120, but not HIV tat, also resulted in impairment of barrier function. Neutralization of gp120 significantly abrogated the effect of HIV. No changes to the barrier function were observed when ECs were exposed to Env defective mutant of HIV. Significant upregulation of inflammatory cytokines, including TNF-alpha, were seen in both intestinal and genital epithelial cells following exposure to HIV-1. Neutralization of TNF-alpha reversed the reduction in TERs. The disruption in barrier functions was associated with viral and bacterial translocation across the epithelial monolayers. Collectively, our data shows that mucosal epithelial cells respond directly to envelope glycoprotein of HIV-1 by upregulating inflammatory cytokines that lead to impairment of barrier functions. The increased permeability could be responsible for small but significant crossing of mucosal epithelium by virus and bacteria present in the lumen of mucosa. This mechanism could be particularly relevant to mucosal transmission of HIV-1 as well as immune activation seen in HIV-1 infected individuals.
authors.affiliation: Center For Gene Therapeutics, Michael G. DeGroote Center for Learning and Discovery, McMaster University, Hamilton, Ontario, Canada.
authors.forename: Aisha
authors.initials: A
authors.lastname: Nazli
authors.forename: Olivia
authors.initials: O
authors.lastname: Chan
authors.forename: Wendy N
authors.initials: WN
authors.lastname: Dobson-Belaire
authors.forename: Michel
authors.initials: M
authors.lastname: Ouellet
authors.forename: Michel J
authors.initials: MJ
authors.lastname: Tremblay
authors.forename: Scott D
authors.initials: SD
authors.lastname: Gray-Owen
authors.forename: A Larry
authors.initials: AL
authors.lastname: Arsenault
authors.forename: Charu
authors.initials: C
authors.lastname: Kaushic
mesh_terms: D000328:Adult; D005260:Female; D005455:Fluorescent Antibody Technique; D015699:HIV Envelope Protein gp120 / Q000378:metabolism*; D015497:HIV-1 / Q000378:metabolism / Q000472:pathogenicity*; D006801:Humans; D008875:Middle Aged; D009092:Mucous Membrane / Q000378:metabolism / Q000821:virology*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D019108:Tight Junctions / Q000473:pathology
chemical_list: D015699:HIV Envelope Protein gp120
references.citation: Biol Reprod. 2007 Dec;77(6):1049-59
references.pmid: 17881767
references.citation: Cell Biol Int. 2007 Oct;31(10):1207-13
references.pmid: 17544707
references.citation: AIDS. 1999 May 7;13(7):823-31
references.pmid: 10357382
references.citation: Eur J Clin Invest. 2006 Jul;36(7):447-58
references.pmid: 16796601
references.citation: Front Biosci (Landmark Ed). 2009 Jan 01;14:2765-78
references.pmid: 19273235
references.citation: Am J Physiol Gastrointest Liver Physiol. 2006 Mar;290(3):G496-504
references.pmid: 16474009
references.citation: Infect Immun. 2001 Sep;69(9):5840-8
references.pmid: 11500462
references.citation: J Virol. 1992 Apr;66(4):2232-9
references.pmid: 1548759
references.citation: Cell Biol Int. 2009 Jan;33(1):78-82
references.pmid: 18938254
references.citation: J Cell Physiol. 1999 Oct;181(1):55-66
references.pmid: 10457353
references.citation: Nat Med. 2006 Dec;12(12):1365-71
references.pmid: 17115046
references.citation: BMC Infect Dis. 2008 Jun 06;8:77
references.pmid: 18538010
references.citation: Curr Opin HIV AIDS. 2008 May;3(3):356-61
references.pmid: 19372990
references.citation: AIDS. 2007 Aug 20;21(13):1723-30
references.pmid: 17690570
references.citation: Am J Physiol Gastrointest Liver Physiol. 2004 Mar;286(3):G367-76
references.pmid: 14766535
references.citation: J Virol. 1999 Jan;73(1):19-28
references.pmid: 9847302
references.citation: Toxicol In Vitro. 1999 Aug-Oct;13(4-5):723-7
references.pmid: 20654541
references.citation: AIDS. 1998 Jan 1;12(1):43-51
references.pmid: 9456254
references.citation: Curr HIV/AIDS Rep. 2009 Feb;6(1):20-8
references.pmid: 19149993
references.citation: Cell. 2007 Dec 14;131(6):1059-71
references.pmid: 18083097
references.citation: J Immunol. 1997 Sep 1;159(5):2382-90
references.pmid: 9278329
references.citation: Clin Exp Immunol. 1993 Jan;91(1):30-6
references.pmid: 8419083
references.citation: Antiviral Res. 2009 Feb;81(2):103-12
references.pmid: 19013198
references.citation: Gut. 1995 Nov;37(5):623-9
references.pmid: 8549936
references.citation: J Infect Dis. 1999 Apr;179(4):859-70
references.pmid: 10068581
references.citation: J Virol. 2007 Nov;81(21):11937-45
references.pmid: 17699569
references.citation: J Reprod Immunol. 2008 Jan;77(1):32-40
references.pmid: 17395270
references.citation: J Clin Pathol. 2005 Jun;58(6):568-72
references.pmid: 15917403
references.citation: Nat Protoc. 2008;3(6):1101-8
references.pmid: 18546601
references.citation: Infect Immun. 2006 Dec;74(12):6581-9
references.pmid: 17015453
references.citation: Mol Hum Reprod. 2007 Jul;13(7):491-501
references.pmid: 17483528
references.citation: Ann N Y Acad Sci. 2000;915:293-303
references.pmid: 11193591
references.citation: J Cell Sci. 2004 Nov 1;117(Pt 23):5509-19
references.pmid: 15494377
references.citation: Nat Immunol. 2006 Mar;7(3):235-9
references.pmid: 16482171
references.citation: J Cereb Blood Flow Metab. 2007 Jan;27(1):123-34
references.pmid: 16685256
references.citation: Mucosal Immunol. 2008 Jan;1(1):23-30
references.pmid: 19079157
references.citation: Allergy. 2008 Sep;63(9):1110-23
references.pmid: 18699929
references.citation: AIDS. 2002 May 3;16(7):983-91
references.pmid: 11953464
references.citation: PLoS Med. 2008 Apr 1;5(4):e81
references.pmid: 18384232
references.citation: Gut. 1999 Jul;45(1):70-6
references.pmid: 10369707
references.citation: J Clin Invest. 1997 Jul 1;100(1):6-10
references.pmid: 9202050
references.citation: J Cereb Blood Flow Metab. 2005 Oct;25(10):1325-35
references.pmid: 15829913
references.citation: Scand J Gastroenterol. 1993 Jul;28(7):573-80
references.pmid: 8362208
references.citation: AIDS. 1995 Apr;9(4):367-73
references.pmid: 7794541
references.citation: AIDS. 2003 Sep 5;17(13):1881-8
references.pmid: 12960820
references.citation: AIDS. 2009 Sep 24;23(15):2050-4
references.pmid: 19710596
references.citation: Nat Rev Immunol. 2008 Jun;8(6):447-57
references.pmid: 18469831
references.citation: Gut. 2009 Feb;58(2):220-7
references.pmid: 18936106
references.citation: J Neurol. 2003 Aug;250(8):901-6
references.pmid: 12928906
references.citation: J Intern Med. 2009 Jan;265(1):58-66
references.pmid: 19093960
references.citation: Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6718-23
references.pmid: 19357303
references.citation: Am J Reprod Immunol. 2005 Feb;53(2):65-76
references.pmid: 15790340
references.citation: Mol Hum Reprod. 2003 Dec;9(12):785-91
references.pmid: 14614040